Open access
Sep 2026
Respiratory Syncytial Virus Vaccine Effectiveness Among US Older Adults, 2023-2024 Season
Key Points Question What is the estimated effectiveness of the respiratory syncytial virus (RSV) vaccines against RSV-related hospitalization and death among US adults 65 years or older? Findings In this cohort study of 14 819 226 Medicare fee-for-service beneficiaries, both the RSVPreF3+AS01 and RSVpreF RSV vaccines p...
Yun Lu, Elizabeth R. Smith, R. McEvoy et al.
· JAMA Network Open · 0 citations